Adventures in pharmacology, aspirin, prostacyclin and nitric oxide

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 19, Issue SUPPL. A, 1997, Pages 3-5

  Moncada, S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NITRIC OXIDE; PROSTACYCLIN;

ARACHIDONIC ACID METABOLISM; CONFERENCE PAPER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; NONHUMAN; PROSTAGLANDIN SYNTHESIS; THROMBOCYTE ADHESION; THROMBOSIS;

ANIMALS; ASPIRIN; EPOPROSTENOL; HUMANS; NITRIC OXIDE;

EID: 0030733570     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Vane, J.R. Inhibition of protaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971, 231: 232-5.
2. Smith, J.H., Willis, A.L. Aspirin selectively inhibits prostaglandin production in human platelets. Nature 1971, 231: 235-7.
3. Ferreira, S.H., Moncada, S., Vane, J.R. Indomethacin and aspirin abolish prostaglandin release from spleen. Nature 1971, 231: 237-9.
4. Moncada, S., Ferreira, S.H., Vane, J.R. Pain and inflammatory mediators. In: Handbook of Experimental Pharmacology. Ferreira, S.H., Vane, J.R. (Eds.). Springer Verlag, Berlin, Heidelberg, New York 1978, (5): 588-616.
5. Hamberg, M., Svensson, J., Samuelsson, B. Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci, USA 1975, 72: 2994-8.
6. 2 from prostaglandin endoperoxides. Nature 1976, 261: 558-60.
7. Moncada, S., Gryglewski, R.J., Bunting, S., Vane, J.R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976, 263: 663-5.
8. Patrono, C. Aspirin and human platelets: From clinical trials to acetylation of cyclooxygenase and back. Trends Pharmacol Sci 1989, 10: 453-8.
9. Antiplatelel Trialists' Collaboration. Br Med J 1994, 308: 159-68.
10. Roth, G.J., Stanford, N., Majerus, P.W. Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA 1975, 72: 3073-6.
11. Vane, J.R., Botting, R.M. The history of antiinflammatory drugs and their mechanism of action. In: New targets in inflammation: Inhibitors of COX-2 or adhesion molecules. Bazan, N., Botting, J., Vane, J.R. (Eds.). Kluwer Academic Publishers, The Netherlands 1996, 1-12.
12. Furchgott, R.F., Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 288: 373-6.
13. Furchgott, R.F. The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol 1984, 24: 175-97.
14. Moncada, S., Palmer, R.M.J., Higgs, E.A. Prostacyclin and endothelium-derived relaxing factor: Biological interactions and significance. In: Thrombosis and Hemostasis. Verstraete, M., Vermylen, J., Lijnen, H.R., Arnout, J. (Eds.). Leuven University Press 1987, 597-618.
15. Palmer, R.M.J., Ferrige, A.G., Moncada, S. Nitric oxide release accounts for the biological activity of endotheliumderived relaxing factor. Nature 1987, 327: 524-6.
16. Palmer, R.M.J., Ashton, D.S., Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988, 333: 664-6.
17. Moncada, S., Palmer, R.M.J., Higgs, E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacological Reviews 1991, 4: 109-42.
18. Moncada, S., Higgs, E.A. The L-arginine:nitric oxide pathway. N Engl J Med 1993, 329: 2002-12.
19. Garthwaite, J. Glutamate, nitric oxide und cell-cell signalling in the nervous system. Trends Neurosci 1991, 14: 60-7.
20. Snyder, S.H., Bredt, D.S. Biological roles of nitric oxide. Sci Am 1992, 266: 68-71.
21. Gillespie, J.S., Liu, X., Martin, W. The neurotransmitter of the non-adrenergic non-cholinergic inhibitory nerves to smooth muscle of the genital system. In: Nitric Oxide from L-arginine: A Bioregulatory System. Moncada, S., Higgs, E.A. (Eds.). Elsevier Science Publishers B.V., Amsterdam 1990, 147-64.
22. Rand, M.J. Nitrergic transmission: Nitric oxide as a mediator of non-adrenergic, non-cholinergic neuroeffector transmission. Clin Exp Pharmacol Physiol 1992, 19: 147-69.
23. Toda, N. Nitric oxide and the regulation of cerebral arterial tone. In: Nitric Oxide in the Nervous System. Vincent, S. (Ed.). Academic Press Ltd., Orlando 1995, 207-25.
24. Nathan, C.F., Hibbs, J.B. Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991, 3: 65-70.
25. Nussler, A.K., Billiarm T.R. Inflammation, immunoregulation and inducible nitric oxide synthase. J Leukoc Biol 1993, 54: 171-8.
26. Wallance, P., Moncada, S. The role of endogenous nitric oxide in septic shock. New Horizons 1993, 1: 77-86.
27. Moncada, S., Higgs, E.A. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995, 9: 1319-30.